X4 Pharmaceuticals to Present at April Investor Conferences

3 years ago

BOSTON, April 04, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel…

Emerging Markets Report: No One Should be Alone

3 years ago

A New Marketing Plan Potentially Could be the Bridge to a Better Tomorrow for Aging Americans An Emerging Markets Sponsored…

COMPASS Pathways to participate in Needham Healthcare conference

3 years ago

LONDON, April 04, 2022 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating…

Selecta Biosciences to Participate at the 21st Annual Needham Virtual Healthcare Conference

3 years ago

WATERTOWN, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated…

Amedisys Completes Acquisition of Evolution Health

3 years ago

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health,…

Amedisys Completes Acquisition of Home Health Assets from AssistedCare Home Health and AssistedCare of the Carolinas

3 years ago

BATON ROUGE, La., April 04, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health,…

OrthoPediatrics Corp. Announces Acquisition of MD Orthopaedics

3 years ago

Expands portfolio with a patented, non-operative solution for the treatment of clubfootWARSAW, Ind., April 04, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics…

Nautilus Biotechnology to Present at EuPA and AACR Meetings

3 years ago

• Co-founder and Chief Scientist Parag Mallick, Ph.D., to present lecture at Annual Congress of the European Proteomics Association (EuPA) •…

Mustang Bio to Present at the Virtual Fortress Biotech R&D Summit Hosted by B. Riley Securities

3 years ago

WORCESTER, Mass., April 04, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on…

Positive New Data from Phase 1/2 Trial of AT-01 Presented at 2022 American College of Cardiology Annual Scientific Session

3 years ago

AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of amyloidSensitivity in those with previously diagnosed cardiac…